Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
22.29%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 2.65Close
$ 1.55 - $ 2.72 52-Week Range
Ticker Information
Ticker
ENTXCompany Name
ENTERA BIO LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQENTERA BIO LTD - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ENTX - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 37K | 22.29% | $ 166K |
| 3/31/2025 | $ 41K | 18.39% | $ 223K |
| 12/31/2024 | $ 46K | 25.41% | $ 181K |
| 9/30/2024 | $ 48K | 48.48% | $ 99K |
| 6/30/2024 | $ 51K | 89.47% | $ 57K |
| 3/31/2024 | $ 55K | 0% | $ 0 |
| 12/31/2023 | $ 56K | 0% | $ 0 |
| 9/30/2023 | $ 59K | 421.43% | $ 14K |
| 6/30/2023 | $ 61K | 277.27% | $ 22K |
| 3/31/2023 | $ 62K | 93.94% | $ 66K |
Key Performance Insights, Last 5 Years
- ENTERA BIO LTD's latest trailing twelve months (TTM) DepAmor % stands at 39.88%.
- Over the past 5 years, ENTERA BIO LTD's average DepAmor % has been 69.66%.
- The median DepAmor % for ENTERA BIO LTD during this period was 44.22%
- ENTERA BIO LTD reached its highest DepAmor % over the past 5 years at 421.43%.
- The lowest DepAmor % recorded by ENTERA BIO LTD in the same timeframe -28.42%
ENTERA BIO LTD's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for ENTERA BIO LTD is calculated as follows: DepAmor [ $ 205K ] / Revenues [ $ 514K ]
(=) DepAmor % [ 39.88% ] ENTX - Depreciation and Amortization Margin, Last 5 years
-28.42%
Minimum
Sep 30, 2022
421.43%
Maximum
Sep 30, 2023
69.66%
Average
44.22%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |